BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11180277)

  • 1. Radioprotective and locomotor responses of mice treated with nimodipine alone and in combination with WR-151327.
    Landauer MR; Castro CA; Benson KA; Hogan JB; Weiss JF
    J Appl Toxicol; 2001; 21(1):25-31. PubMed ID: 11180277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiation.
    Landauer MR; Davis HD; Dominitz JA; Weiss JF
    Toxicology; 1988 May; 49(2-3):315-23. PubMed ID: 2836973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioprotection by vitamin E: injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice.
    Srinivasan V; Weiss JF
    Int J Radiat Oncol Biol Phys; 1992; 23(4):841-5. PubMed ID: 1319980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined modality radioprotection: the use of glucan and selenium with WR-2721.
    Patchen ML; MacVittie TJ; Weiss JF
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1069-75. PubMed ID: 2161407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WR-151327 increases resistance to Klebsiella pneumoniae infection in mixed-field- and gamma-photon-irradiated mice.
    Ledney GD; Elliott TB; Harding RA; Jackson WE; Inal CE; Landauer MR
    Int J Radiat Biol; 2000 Feb; 76(2):261-71. PubMed ID: 10716647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein treatment protects mice from ionizing radiation injury.
    Landauer MR; Srinivasan V; Seed TM
    J Appl Toxicol; 2003; 23(6):379-85. PubMed ID: 14635262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
    Fatome M; Courteille F; Laval JD; Roman V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):21-9. PubMed ID: 3036725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice.
    Landauer MR; Davis HD; Dominitz JA; Weiss JF
    Pharmacol Biochem Behav; 1987 Jul; 27(3):573-6. PubMed ID: 2821556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721.
    Weiss JF; Hoover RL; Kumar KS
    Free Radic Res Commun; 1987; 3(1-5):33-8. PubMed ID: 2854528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation protection of rat parenchymal hepatocytes with S-2-(3-aminopropylamino)ethylphosphorothioic acid.
    Jirtle RL; Pierce LJ; Crocker IR; Strom SC
    Radiother Oncol; 1985 Nov; 4(3):231-7. PubMed ID: 3001838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
    Bogo V; Jacobs AJ; Weiss JF
    Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical protection against gastrointestinal radiation injury in mice by WR 2822, WR 2823, or WR 109342 after 4 MeV X ray or fission neutron irradiation.
    Connor AM; Sigdestad CP
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):547-51. PubMed ID: 7107377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin.
    Ledney GD; Elliott TB; Landauer MR; Vigneulle RM; Henderson PL; Harding RA; Tom SP
    Adv Space Res; 1994 Oct; 14(10):583-6. PubMed ID: 11539995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in radioprotection through the use of combined agent regimens.
    Weiss JF; Kumar KS; Walden TL; Neta R; Landauer MR; Clark EP
    Int J Radiat Biol; 1990 Apr; 57(4):709-22. PubMed ID: 1969903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
    Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
    Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice against mixed fission neutron-gamma (n: gamma = 1:1) irradiation by WR-2721, 16,16-dimethyl PGE2, and the combination of both agents.
    Steel LK; Walden TL; Hughes HN; Jackson WE
    Radiat Res; 1988 Sep; 115(3):605-8. PubMed ID: 2845467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
    Grigsby P; Maruyama Y
    Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological evaluation of WR-151327 administered orally in irradiated and non-irradiated male mice.
    Steel-Goodwin L; Kendrick JM; Egan JE; Eckstein JM
    Ann Clin Lab Sci; 1992; 22(3):182-8. PubMed ID: 1503385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.